Inhibitors and Approved Drugs
Product name
Size
Description
Download
45214 compounds
Complete stock database of drugs and inhibitors
4541 compounds
The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.
804 compounds
Drug repositioning aims to reuse “old” drugs to treat diseases outside their approved indication(s).
515 compounds
The library is intended to represent the "top" molecules while capturing many targets.
52984 compounds
Small molecule inhibitors can bind to target proteins and reduce their biological activity and are often used as tools in biological and pharmacological research. Small molecule inhibitors have many advantages.
244 compounds
Drug repositioning aims to reuse “old” drugs to treat diseases outside their approved indication(s).
300 compounds
Drug repositioning aims to reuse “old” drugs to treat diseases outside their approved indication(s).
Tags
Custom ChemistryNovel Scaffolds and Discovery LibrariesCustom Building Blocks for DNA Encoded LibrariesScale up SynthesisMacrocycle CompoundsIn silico Drug Design (CADD)PROTACADME, DMPKMedicinal ChemistryDNA Encoded Libraries-CDI-CapabilitiesDiscovery BiologyAssay DevelopmentHigh Throughput Screening (HTS)Animal ModelsToxicology and SafetyChemistry, Manufacturing and ControlsPre-Plated SetRepresentative CompoundsNatural-Product3D-PharmacophoreMCE-18RepresentativeSoluble DiversityTargeted DiversitySmartTMAntiviralGPCR3DPhenotypic ScreeningCNS activityTranscription FactorsDrugs LibraryTarget ActivityTherapeutical DiversityCNSIon ChannelsProteases HumanKinases HumanPhosphatases HumanReceptors HumanOpportunistic PathogensCancerCardiovascularMetabolicImmune systemInfectionsMusculoskeletalDigestive systemRespiratory tractOtorhinolaryngologicNervous systemEyeMaleFemaleHemic and lymphaticCongenitalSkinEndocrineAnimalWoundsKinasesProteasesPhosphatasesNuclear receptorsOthersPPI modulatorsReceptor's ligandsEpigeneticMimeticsCyclic compoundsFragmentsPoolChemical classes AgroAllosteric Inhibitors